494 related articles for article (PubMed ID: 27328271)
41. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.
Yiannaki EE; Tzioufas AG; Bachmann M; Hantoumi J; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
Clin Exp Immunol; 1998 Apr; 112(1):152-8. PubMed ID: 9566804
[TBL] [Abstract][Full Text] [Related]
42. Investigation of autoantibodies to SP-1 in Chinese patients with primary Sjögren's syndrome.
Xuan J; Wang Y; Xiong Y; Qian H; He Y; Shi G
Clin Immunol; 2018 Mar; 188():58-63. PubMed ID: 29292085
[TBL] [Abstract][Full Text] [Related]
43. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome.
Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC
J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806
[TBL] [Abstract][Full Text] [Related]
44. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
45. Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients.
Zandbelt M; te Boome L; Klasen I; van de Putte L; van den Hoogen F
Clin Exp Rheumatol; 2009; 27(3):536. PubMed ID: 19604453
[No Abstract] [Full Text] [Related]
46. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
47. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
48. Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
Everett S; Vishwanath S; Cavero V; Shen L; Suresh L; Malyavantham K; Lincoff-Cohen N; Ambrus JL
BMC Ophthalmol; 2017 Mar; 17(1):20. PubMed ID: 28270126
[TBL] [Abstract][Full Text] [Related]
49. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
50. Autoantigen-specific memory B cells in primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Bredholt G; Brun JG; Brokstad KA
Scand J Immunol; 2012 Jan; 75(1):61-8. PubMed ID: 21916919
[TBL] [Abstract][Full Text] [Related]
51. Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens.
Halse AK; Wahren M; Jonsson R
Autoimmunity; 1996; 23(1):25-34. PubMed ID: 8871759
[TBL] [Abstract][Full Text] [Related]
52. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
53. Identification of specific autoantigens in Sjögren's syndrome by SEREX.
Uchida K; Akita Y; Matsuo K; Fujiwara S; Nakagawa A; Kazaoka Y; Hachiya H; Naganawa Y; Oh-Iwa I; Ohura K; Saga S; Kawai T; Matsumoto Y; Shimozato K; Kozaki K
Immunology; 2005 Sep; 116(1):53-63. PubMed ID: 16108817
[TBL] [Abstract][Full Text] [Related]
54. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
[TBL] [Abstract][Full Text] [Related]
55. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
Kabeerdoss J; Sandhya P; Danda D
Int J Rheum Dis; 2017 Nov; 20(11):1763-1766. PubMed ID: 29152879
[TBL] [Abstract][Full Text] [Related]
56. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
Suresh L; Malyavantham K; Shen L; Ambrus JL
BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
[TBL] [Abstract][Full Text] [Related]
57. Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?
Venables PJ; Shattles W; Pease CT; Ellis JE; Charles PJ; Maini RN
Clin Exp Rheumatol; 1989; 7(2):181-4. PubMed ID: 2736832
[TBL] [Abstract][Full Text] [Related]
58. Identification of Moesin as a Novel Autoantigen in Patients with Sjögren's Syndrome.
Zhang Y; Hussain M; Yang X; Chen P; Yang C; Xun Y; Tian Y; Du H
Protein Pept Lett; 2018; 25(4):350-355. PubMed ID: 29557737
[TBL] [Abstract][Full Text] [Related]
59. Anti-CENP-H antibodies in patients with Sjogren's syndrome.
Hsu TC; Chang CH; Lin MC; Liu ST; Yen TJ; Tsay GJ
Rheumatol Int; 2006 Feb; 26(4):298-303. PubMed ID: 15700116
[TBL] [Abstract][Full Text] [Related]
60. HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome.
Hida A; Kawabe Y; Kawakami A; Migita K; Tominaga M; Nakamura H; Eguchi K
Ann Rheum Dis; 1999 May; 58(5):320-2. PubMed ID: 10225819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
